iRadimedIRMD
About: iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Employees: 160
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
209% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 11
69% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 39
14% more funds holding
Funds holding: 143 [Q3] → 163 (+20) [Q4]
12% more capital invested
Capital invested by funds: $339M [Q3] → $381M (+$42.3M) [Q4]
1.46% more ownership
Funds ownership: 53.24% [Q3] → 54.7% (+1.46%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
81% less call options, than puts
Call options by funds: $33K | Put options by funds: $176K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Roth MKM Jason Wittes 35% 1-year accuracy 7 / 20 met price target | 36%upside $72 | Buy Reiterated | 14 Feb 2025 |
Financial journalist opinion









